Articles
Why More Data Doesn’t Automatically Mean Better AI in Drug Discovery
When DeciBio asked nine senior pharma executives what was holding back AI adoption in R&D, the answer wasn't algorithms or compute. Three of the top four barriers they named were data problems, and low-quality data was cited by every...
Articles
Beyond the Purity Percentage
How pharmaceutical and life-science R&D teams can qualify high-purity specialty inorganic salts using rubidium chloride and rubidium carbonate to illustrate the importance of impurity profiles, analytical evidence, packaging and supplier consistency.
Rubidium Carbonate
Rubidium Chloride
Qualification at a glance
Focus: Impurity profile,...
Articles
The Engine of Cell Therapy Success: Why Analytical Development Determines Whether Promising Cell Therapies Reach Patients
How advanced analytical methods, potency assays, and immune profiling are shaping the future of cancer cell therapies
Cell therapies have transformed the treatment landscape for patients with cancer and other serious diseases. Innovations such as CAR-T cell therapies have demonstrated...
Articles
Stevanato Group and Syntegon Join Forces to Drive Innovation
Quality first: advanced manufacturing process for EZ-fill® cartridges
The development of GLP-1 drugs has revolutionized the treatment of diabetes and obesity – and is a catalyst for breaking new grounds in ready-to-use cartridge manufacturing. Primary packaging provider Stevanato Group has...
Articles
Move Beyond Visibility: Why Cold Chain Orchestration is Now Essential for Thermal Assurance
As life sciences supply chains become more volatile, real-time visibility is increasingly the baseline for operational excellence. The next frontier is orchestration: turning fragmented signals into decisions that prevent excursions, reduce waste, and protect patients. Sam Durham, Product Manager...
Articles
Speed in complex drug development is the late-phase outcome of early-phase decisions
Late-stage development is where timelines tighten, complexity increases, and the demand for speed becomes most visible. Execution is often treated as the lever—compressed timelines, parallel workstreams, faster decision-making.
But speed is rarely created at that stage. It is shaped earlier,...
Articles
The Evolution of Field Execution in Specialty Pharma: From Coverage to Engagement
Why Field Execution Must Evolve
Field execution — how pharma companies organize, direct, and deliver commercial and medical interactions with healthcare professionals (HCPs), prescribers, and institutional decision-makers (collectively, "customers") — is a major contributor to commercial success. Accordingly, over the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read













